FINDRISC (Finnish Diabetes Risk Score)

FINDRISC estimates the 10‑year risk of developing type 2 diabetes using simple non‑laboratory factors.

Age, years
< 45045 - 54+255 - 64+3> 64+4
BMI, kg/m2
< 25025 - 29.9+1≥ 30+3
Waist circumference
< 94 cm (37 in)094 to < 102 cm (37 to < 40 in)+3≥ 102 cm (≥ 40 in)+4
Use of BP medication
No0Yes+2
Hx of high blood glucose
No0Yes+5
Physical activity
≥ 4 hr/week0< 4 hr/week+2
Daily consumption of vegetables, fruits or berries
Yes0No+1
Family Hx of diabetes
No0Yes, 2nd degree relative+3Yes, 1st degree relative+5

Indications for Use

Used for adults undergoing noncardiac surgery to estimate 30‑day MACE risk, especially when determining whether risk is <1% vs ≥1% to guide further testing or management (AHA/ACC 2024 1 [Level I evidence]). Applies best to elective/urgent surgery; poorly validated in vascular surgery 2 [Level II evidence].

Used to screen asymptomatic adults in primary care to estimate 10‑year type 2 diabetes risk and guide lifestyle intervention; widely used epidemiologic tool with moderate discrimination 3 [Level II evidence].

Insights & Cautions

Identifies high‑risk individuals reasonably well but has moderate discrimination (AUC ~0.69–0.76) and high false‑positive rates at common cutoffs 1 [Level I evidence]. Performance varies by population and often requires recalibration; accuracy is lower in older adults 2 [Level II evidence]. Newer multivariable or laboratory‑based models consistently outperform it (AUC 0.66 vs 0.87) 3 [Level II evidence].